AZN: Astrazeneca Plc - Full Company Report
Enter Ticker:
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
General Information
ASTRAZENECA PLC
ZENECA GROUP PLCwww.astrazeneca.com
Industry
MED-DRUGS
Sector:
Medical
Fiscal Year End
December
Last Reported Quarter
09/30/09
Next EPS Date
01/28/2010
Price and Volume Information
Zacks Rank
Yesterday's Close
45.19
52 Week High
47.61
52 Week Low
29.96
Beta
0.63
20 Day Moving Average
1,351,301.75
Target Price Consensus
49.21
% Price Change
4 Week
-0.80
12 Week
-3.20
YTD
9.24
% Price Change Relative to S&P 500
4 Week
-1.87
12 Week
-8.74
YTD
-9.59
Share Information
Shares Outstanding (millions)
1,449.45
Market Capitalization (millions)
64,964.48
Short Ratio
3.16
Last Split Date
04/08/1998
Dividend Information
Dividend Yield
4.66%
Annual Dividend
$2.09
Payout Ratio
0.36
Change in Payout Ratio
-0.04
Last Dividend Payout / Amount
NA / $0.00
EPS Information
Current Quarter EPS Consensus Estimate
1.46
Current Year EPS Consensus Estimate
6.40
Estimated Long-Term EPS Growth Rate
-3.00
Next EPS Report Date
01/28/2010
Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)
3.10
30 Days Ago
3.00
60 Days Ago
3.00
90 Days Ago
3.00
Fundamental Ratios
P/E
Current FY Estimate:
7.03
Trailing 12 Months:
7.69
PEG Ratio
-2.34
EPS Growth
vs. Previous Year
22.69%
vs. Previous Quarter
-10.98%
Sales Growth
vs. Previous Year
5.47%
vs. Previous Quarter:
3.04%
Price Ratios
Price/Book
3.32
Price/Cash Flow
7.55
Price / Sales
2.03
ROE
09/30/09
51.63
06/30/09
49.52
03/31/09
47.43
ROA
09/30/09
17.66
06/30/09
16.85
03/31/09
15.69
Current Ratio
09/30/09
1.36
06/30/09
1.26
03/31/09
1.13
Quick Ratio
09/30/09
1.23
06/30/09
1.14
03/31/09
1.01
Operating Margin
09/30/09
26.36
06/30/09
25.52
03/31/09
23.76
Net Margin
09/30/09
32.63
06/30/09
31.21
03/31/09
30.17
Pre-Tax Margin
09/30/09
32.63
06/30/09
31.21
03/31/09
30.17
Book Value
09/30/09
13.49
06/30/09
12.07
03/31/09
10.44
Inventory Turnover
09/30/09
3.50
06/30/09
3.56
03/31/09
3.37
Debt-to-Equity
09/30/09
0.53
06/30/09
0.57
03/31/09
0.65
Debt to Capital
09/30/09
34.48
06/30/09
36.68
03/31/09
39.76
Sponsored Links 
-0.37